0-4 severe depression requiring immediate resuscitation
5 min APGAR SOCRE
0-7 high risk for subsequent central nervous system and other organ system dysfunction
scattered vesicles on an erythematous base, usually on the face and trunk, result from obstruction of the sweat gland ducts; this condition disappears spontaneously within weeks
Usually appearing on days 2 to 3 of life, this rash consists of erythematous macules with central pinpoint vesicles scattered diffusely over the entire body. They appear similar to flea bites. These lesions are of unknown etiology but disappear within 1 week of birth
sceen more commonly in black infants, the rash presents at birth as small vesiculopustules over a brown macular base; these can last for several months
Pinhead sized smooth white raised areas without surrounding erthema on the nose, chin, and forehead result from retention of sebum in the openings of the sebaceous glands. Although occasionally present at birth, milia usually appears within the first few weeks and disappears over several weeks
First drug for most forms of stable narrow-complex SVT. Effective in terminating those due to reentry involving AV node or sinus node.
May consider this drug for unstable narrow-complex reentry tachycardia while preparations are made for cardioersion.
This drug does not conert A.Fib, A. Flutter, or VT
1. Place patient in mild reverse trendelenberg position before aministration of this drug
2. initial bolus of 6mg given rapidly over 1 to 3 seconds followed by NS flush (20ml) then elevate arm
3. a second dose of 12mg can be given in 1 to 2 mins if needed. remember to flush and elevate
p. 165 ALS Book
Because this drug is associated with toxicity, it is indicated for use in patients with life-threatening arrhythmias when administered with appropriate monitoring:
-VF/pulselss VT unpresonsive to shock delivery. CPR, and a vasopressor
-Recurrent, hemodynamically unstable VT
First Dose = 300mg IV/IO
Second Dose = 150mg IV/IO
p. 165 ACLS Book
First drug for symptomatic sinus bradycardia.
what is the dosage?
Dose: 0.5 mg IV every 3 to 5 mins as needed not to exceed 3mg
p.166 ACLS Book
second-line drug for symptomatic sinus bradycardia
p.166 ACLS Book
first line drug during cardiac arrest: VF, pulseless VT, asystole, PEA
Dose: 1mg (10ml of 1: 10,000 solution) administered every 3 to 5 mins during resuscitation
Follow each dose with NS flush and raise arm
Alternative to amiodarone in cadiac arrest from VF/VT
Dose: 1 to 1.5mg/kg IV/IO
p. 167 ACLS Book
May be used as alternative pressor to epinepherine in treatment of adult shock-refractory VF
Dose: One dose of 40 units IV/IO push may replace either first or second dose of epi.
What are the treatable causes that you should remember when evaluating a pt during ACLS? (H's and T's)